Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes

Mesenchymal stem cells (MSCs) transplantation is a promising therapeutic strategy for type 1 diabetes (T1D). However, little is known on whether MSC transplantation can benefit T1D patients with ketoacidosis and its potential actions. Here, we show that infusion with bone marrow MSCs preserves β-cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lirong, Hui, Hui, Jia, Xiaolei, Zhang, Jie, Liu, Ying, Xu, Qianyue, Zhu, Dalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131346/
https://www.ncbi.nlm.nih.gov/pubmed/27905403
http://dx.doi.org/10.1038/srep37894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131346/
https://www.ncbi.nlm.nih.gov/pubmed/27905403
http://dx.doi.org/10.1038/srep37894

Ejemplares similares